Delivery Order SPE2DB22D1017-SPE2DB24FF6ZG
Award Date
5/1/24
Potential Completion Date
5/2/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of the pharmaceutical product XCOPRI 100 MG TABLET 30S. The award is for a Firm Fixed Price contract with a ceiling value of $1,623.99 and a completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has a total ceiling value of $5,916.75 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received an indefinite delivery contract (IDC) from DLA, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XCOPRI 50 MG TABLET 30S. The order has a ceiling value of $3,307.26 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA that serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for XCOPRI 200 MG TABLET 30S, with a firm fixed price of $2,348.10 and a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product XCOPRI 100 mg tablets. The contract has a ceiling value of $1,624.02 and runs through February 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...
This award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,959.47 and a performance period ending on August 29, 2024. The contract is a firm-fixed-price type, with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The order has a ceiling value of $3,247.98 and an ultimate completion date of June 26, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order under an Indefinite Delivery Contract (IDC)...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug XCOPRI 50 MG TABLET 30S. The contract has a ceiling value of $2,754.05 and is set to expire on September 11, 2024. It is a Firm Fixed Price contract with no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is the prime contractor for this award. The contract supports the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of the pharmaceutical product XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,623.99 and is a Firm Fixed Price Delivery Order with a completion date of July 10, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen...